Professional
Added to YB: 2026-08-10
Pitch date: 2026-08-05
041830.KQ [neutral]
InBody Co.,Ltd
Author Info
Founder of Smoak Capital who shares analysis on stocks on Twitter and in his fund letter. Follow on Twitter.
Company Info
InBody Co.,Ltd provides body composition analysis solutions worldwide. It offers body composition analyzers, automatic blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands.
Market Cap
KRW 933.9B
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
15.41
P/E
22.47
EV/Sales
3.23
Sector
Health Care Equipment and Supplies
Category
growth
Smoak Capital Portfolio Holding: InBody Co.,Ltd
041830.KQ (holding update): Global leader in body composition devices, ~15% 10yr rev CAGR. Q1'26 NA +32%, EU +41%, OpInc +86% YoY. GLP-1 tailwind (muscle-loss tracking), drug/format-agnostic. Direct-sales buildout done, margins recovering to mid-high 20s. 176M-record dataset = switching costs. 7.6x EV/2026e EBIT vs 15-30x comps, 1/3 mktcap net cash. Undervalued at inflection.
Read full article (4 min)